The first discoveries of people infected with the COVID-19 virus were in Wuhan. Five years after the initial lockdown was ...

“Although individual vaccines have been developed and approved for use in humans against SARS-CoV-2 and influenza viruses, there is no vaccine approved to simultaneously protect against both viral ...

It started as a respiratory illness – or so everyone thought. But it quickly became apparent that SARS-CoV-2, the virus that ...

Researchers have developed a powerful tool that can detect variants of SARS-CoV-2 with high transmission potential before they become widespread.

A 41-year-old man was evaluated for swelling in the ankles and syncope. CT of the chest showed bilateral mediastinal and ...

The UK's capital markets are a vital economic driver, and also a significant source of money laundering risk. This is a difficult area of risk ...

During the COVID-19 pandemic, health worker Maria Tereza Malheiros Sapienza's curiosity was aroused by her immunity to ...

Researchers have developed a powerful tool that can detect variants of SARS-CoV-2 with high transmission potential before ...

HealthDay News — The risk for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is increased following COVID-19, according to a study published online Jan. 13 in the Journal of General ...

Leukocyte count, a widely available and inexpensive clinical marker of inflammation, may help predict the severity of long COVID symptoms in postmenopausal women, researchers reported.

“Taken together, these results indicate that, once PNP or NNP patients develop neuro-PASC, whether they contracted SARS-CoV-2 infection prior to, or after SARS-CoV-2 vaccination makes little ...